Source:http://linkedlifedata.com/resource/pubmed/id/21077737
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2010-12-7
|
pubmed:abstractText |
One hundred and fifty hemato-oncologists and nuclear medicine specialists from more than 20 countries joined in April 2010 the 2-day Second International Workshop on interim PET in lymphoma. During the nuclear medicine session the advantages of the five-point scale Deauville criteria for interim PET reporting over the other sets of visual criteria were presented. The specific problems of PET reporting in escalation/de-escalation trials in Hodgkin lymphoma (HL) were addressed as well as the limitations of visual analysis for early PET evaluation in non-Hodgkin lymphoma (NHL). The applicability, efficacy, and reproducibility of quantitative criteria (?SUV(max) analysis and tumor/liver SUV ratio) for interim PET in NHL were reported. In retrospective and prospective series. Some of the interim PET-based clinical trials ongoing worldwide in HL and NHL were reported. In early-stage HL, three trials aimed at determining the feasibility of omitting radiotherapy in interim PET negative patients, and in advanced-stage HL two PET-based ABVD escalation or BEACOPP de-escalation trials, in NHL two studies reported preliminary results of interim PET in follicular lymphoma, in DLBCL a round-table discussion pointed out the lack of definite criteria for interim PET, and a few observational studies in DLBCL reported the comparison of the various techniques of interim PET reporting (visual versus quantitative). The preliminary results of two international validation studies of the five-point scale criteria in HL and NHL launched in 2009 were reported. The presentations of the meeting are available on http://eitti.free.fr.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1029-2403
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2171-80
|
pubmed:meshHeading |
pubmed-meshheading:21077737-Animals,
pubmed-meshheading:21077737-Clinical Trials as Topic,
pubmed-meshheading:21077737-Congresses as Topic,
pubmed-meshheading:21077737-Expert Testimony,
pubmed-meshheading:21077737-France,
pubmed-meshheading:21077737-Humans,
pubmed-meshheading:21077737-International Cooperation,
pubmed-meshheading:21077737-Lymphoma,
pubmed-meshheading:21077737-Positron-Emission Tomography,
pubmed-meshheading:21077737-Review Literature as Topic,
pubmed-meshheading:21077737-Validation Studies as Topic
|
pubmed:year |
2010
|
pubmed:articleTitle |
Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010.
|
pubmed:affiliation |
Nuclear Medicine Department, Hôpital Henri Mondor, University Paris Est, Créteil, France. michel.meignan@hmn.aphp.fr
|
pubmed:publicationType |
Congresses
|